The list of safe stocks for long-term investments in 2024 is finalized

In the context of current market developments, the assessment of safe stocks serves as a sought-after guide for investors. UnitedHealth Group holds a prominent position in this regard. The decision of the Federal Reserve is a key driver of recent market fluctuations. Drew Pettit, US equity strategist at Citi, emphasized in an interview with Yahoo Finance that the market has not yet reached its peak. The interplay of Federal Reserve decisions and potential developments in the labor market could restore investor confidence and pave the way for a recovery. According to Pettit, cyclical and secular stocks have gained ground over the past quarter, but have not yet reached their peak. While some growth segments outperform others, mature business models benefit from marginal revenue increases. Despite potential slowdowns, Pettit remains confident in technology stocks, but advises a more vigilant focus on other neglected market areas such as consumer goods and cyclical sectors. Liz Young Thomas from SoFi recently commented on current trends in an interview with CNBC. She highlights that market returns have been remarkable since the beginning of the easing cycle, and growth could continue until the end of 2024. According to her, the next 30 to 60 days are crucial for understanding the intentions behind interest rate cuts. More than 80% of S&P 500 companies are trading above the 200-day average, suggesting a robust market recovery. However, Thomas emphasizes that stock valuations are overestimated, and there should be an increased focus on fundamental values and consistent earnings growth, rather than pure valuation multiples. In selecting the safest stocks for 2024, we have thoroughly reviewed numerous reports and databases such as Finviz. The list includes companies with impressive growth rates and a steady dividend yield. UnitedHealth Group ranks particularly high; the healthcare provider has consistently expanded, recently recording $98.9 billion in revenue, an increase of nearly $6 billion. Looking ahead, the company plans innovative measures in healthcare and aims to reduce costs for chronically ill patients. Experts are optimistic that UnitedHealth Group, with a growth potential of 5% within twelve months, remains a worthwhile investment. With billion-dollar holdings, Fisher Asset Management remains one of the significant shareholders. Despite promising forecasts for UnitedHealth Group (UNH), Invesco Distributors highlights the potentially faster profit opportunities of AI stocks, suggesting they might surpass the healthcare giant.